🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06060886
Treatments Being Tested
The purpose of this research of 400 participants is to determine whether a ...
Status
Completed
Location
VA Medical Center, Tuscaloosa
Start Date
2006-10
Trial ID
NCT00099983
Treatments Being Tested
This trial examines the efficacy of cannabidiol (CBD) versus risperidone fo...
Status
Active Not Recruiting
Location
Center for Neuropsychiatric Schizophrenia Research
Start Date
2021-06-01
Trial ID
NCT04105231
Treatments Being Tested
The study examines and illustrates the utility of utilizing actigraphic mea...
Status
Completed
Location
Child Psychopharmacology Institute
Start Date
2008-05
Trial ID
NCT00723580
Treatments Being Tested
The purpose of this study is to evaluate efficacy, safety and tolerance of ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT01726335
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness, safety and tole...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00246259
Treatments Being Tested
The Optimal Treatment for Treatment-resistant Schizophrenia...
Status
Unknown
Location
DTliu
Start Date
2016-11
Trial ID
NCT02926976
The purpose of this study is to evaluate the outcome of medication disconti...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00378092
This study compares the efficacy and effectiveness of two of the second-gen...
Status
Unknown
Location
University Hospital Marques de Valdecilla
Start Date
2014-06
Trial ID
NCT03090503
Treatments Being Tested
This is a Phase 1, open-label study to evaluate the safety and pharmacokine...
Status
Completed
Location
Glendale Adventist Medical Center
Start Date
2012-07
Trial ID
NCT01592110